26 results
Page 2 of 2
424B5
22oe55rx3zfa 8ym
11 May 20
Prospectus supplement for primary offering
9:23am
6-K
EX-99.1
fwz9axis9g2q7wbo
23 Oct 18
Newly Granted European Composition of Matter Patent Extends Exclusive Protection for VBL Therapeutics’ Lead Drug Candidate VB-111 until October 2033
8:16am
20-F
EX-4.18
mg8xtalo5idyemcv
25 Mar 15
Annual report (foreign)
12:00am
F-1/A
EX-10.11
vuocdlyzx
18 Jul 14
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-10.5
zv846vr36
18 Jul 14
Registration statement (foreign) (amended)
12:00am